Company Overview and News

0
Smart water company Essentia is up for sale

2018-06-14 cnbc
Premium water company Essentia has hired an investment bank to run an auction for the company, sources familiar with the matter told CNBC, and it could fetch $500 million or more in a sale.
ABI

0
Which Brewer Brews The Best Stock?

2018-06-12 seekingalpha
I put most emphasis on the Debt to Equity ratio, because a low ratio makes room for acquisitions.
ABI

17
AB InBev Stock Declines on Soft Earnings: Time to Offload?

2018-06-11 zacks
Anheuser-Busch InBev SA/NV (BUD - Free Report) , alias AB InBev, has been putting up a dismal show lately, owing to its dismal earnings trend. First-quarter 2018 marked AB InBev’s return to the negative earnings surprise trend, after a beat in the preceding quarter. While solid sales growth and synergies from cost savings continued to aid results, higher sales and marketing expenses ahead of the FIFA World Cup, along with fall in other operating income due to difficult comparisons, were impediments.
IPAR XEL BUD HSC ABI AHBIF SAM

14
No One Taps Better Than Molson Coors

2018-06-08 seekingalpha
Molson Coors is struggling to grow revenue and I expect no acquisitions in the near future to help top line grow.
BUD ABI AHBIF

12
GRAPHIC-Take Five: World markets themes for the week ahead

2018-06-08 reuters
LONDON, June 8 (Reuters) - Following are five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them.
MS.PRI ABI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

0
Change a-brewing as Brits snub booze for alcohol-free beer, wine

2018-06-06 lifestyle.inquirer.net
The alcohol industry has seized on the trend for alcohol abstinence in Britain, where sales in 2017 of alcohol-free wine rose eight percent from 2015, according to consumer researcher Kantar Worldpanel. Image: Daniel LEAL-OLIVAS – AFP
ABI

18
Investors in Chinese Brewing Stocks May Have Beer Goggles On - Bloomberg

2018-06-05 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BUD 0168 ABI AHBIF MSCI

35
Sometimes, Greed Can Be Good

2018-06-02 seekingalpha
We will discuss and compare five large and well-known beverage companies to find out the winners.
STZ.B GEC GE KMI.WS STZ KMI.PRA PEP ABI KMI GNE KMR CVB KMRFZ DEO

15
Why Is Altria (MO) Up 2% Since Its Last Earnings Report?

2018-05-28 zacks
It has been about a month since the last earnings report for Altria Group, Inc. (MO - Free Report) . Shares have added about 2% in that time frame.
DUKH AMKR ABI DUK MO

0
Beer maker AB InBev pumps up the volume in Africa

2018-05-22 reuters
JOHANNESBURG/BRUSSELS/LONDON (Reuters) - Sitting outside the ramshackle Vimba Tavern in Johannesburg’s Alexandra township, Patrick Mashego swigs from a one-liter bottle of Carling Black Label, South Africa’s most popular beer.
ABI

27
The Nest Egg Portfolio: BT Group Finds A Solution For The Pension Deficit, But The Market Doesn't Like It

2018-05-20 seekingalpha
The underlying operating cash flows remain stable, and even after taking the higher capex into account, the dividend remains fully covered.
BT.A RDS.B RDS.A ELCPF BTGOF RDSB OCI RDSA BT ABI RYDBF OCINF RYDAF

72
PepsiCo Is The Perfect 3G Target

2018-05-18 seekingalpha
3G has historically focused on branded consumer businesses with high market share and attractive product margins, but bloated cost structures.
BRK.A PLKI BUD PEP ABI UN KHC KO AHBIF QSR QSR.WI ABEV

19
Altria Group (MO) Annual Meeting of Shareholders Conference (Transcript)

2018-05-17 seekingalpha
Altria Group, Inc. (NYSE:MO) Annual Meeting of Shareholders Conference Call May 17, 2018 9:00 AM ET
BUD ABI AHBIF MO

31
Top Research Reports for General Dynamics, Enbridge & CSX Corporation

2018-05-15 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Enbridge (ENB) and CSX Corp. (CSX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
GD ENB WM HUM SE ENB AVY ABI GM.WS.A GM.WS.B GM.WS.C CSX GM GM.WSB

4
BT Group Plc (BT) Q4 2018 Results - Earnings Call Transcript

2018-05-10 seekingalpha
Good morning and welcome to BT's Full-Year Results and Strategy Update Presentation. Presenting from the stage today is Jan du Plessis, Chairman of BT; Gavin Patterson, Chief Executive; and Simon Lowth, Chief Financial Officer. Also present are the CEOs of our customer-facing units. Before we begin, I need to let you know that there is no planned fire drill today. If you hear the alarm, listen for announcements and follow the instructions.
BT.A ABI BTGOF BT

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to EBR:ABI / AB INBEV on message board site Silicon Investor.

Reliability Inc (REAL) ADMA - http://www.admabiologics.com/
IGPK Integrated Cannabis Solutions CBIS.OB Cannabis Science
Oil prices boosted with Saudi Arabia-Iran tensions over Shiu0027 Cannabis saves lives.
Sabina Gold u0026 Silver (TSX:SBB OTC:SGSVF) Repeal Cannabis Prohibition for San Jose Residents Project
Northern Abitibi Mining (NAI-ASE) ABIOMED --an under valued small co.